Company Update Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Receipt of EIR from USFDA for Inspection conducted at manufacturing facility of Company ''s subsidiary Time Cap Laboratories, INC